Pathios Therapeutics Revenue

Biotechnology Research • 99 Park Drive, Milton, United Kingdom • 21-50 Employees

Pathios Therapeutics revenue & valuation

Annual revenue	$760,000
Revenue per employee	$35,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,500,000
Total funding	$25,688,100

Key Contact at Pathios Therapeutics

Paul G Higham

Chief Executive Officer

Company overview

Headquarters	99 Park Drive, Milton, Oxfordshire OX14 4RR, GB
Phone number	+4410641754
Websites	pathios.com pathiostherapeutics.com
NAICS	541714
SIC	873
Founded	2017
Employees	21-50
Socials

Pathios Therapeutics Email Formats

Pathios Therapeutics uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@pathios.com), used 63.6% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@pathios.com	63.6%
{first name}	john@pathios.com	27.3%
{first initial}.{last name}	j.doe@pathios.com	9.1%

About Pathios Therapeutics

Pathios Therapeutics are world-leading experts with unique expertise in GPCR drug development, focused on GPR65 as a high-value immunology target with robust genetic links to multiple human diseases. Our clinical-stage oncology programme leverages cutting-edge proprietary genetic insights, transcriptomics, and functional immunology of GPR65 as a key immune cell sensor of acidosis in multiple pathological environments, to bring about a revolutionary new approach to treating a broad spectrum of cancers. We are also building an emerging pipeline in neuroinflammatory and neurodegenerative disorders leveraging the broader immunological roles of this receptor in cell types such as microglia. Based in in Oxford, UK, Pathios combines a team of experienced scientific leaders with strategic external partnerships. We are supported by top tier investors Canaan, Brandon Capital Partners and Bristol Myers Squibb. Pathios is part of the M:M Bio ecosystem, which integrates experienced drug discovery expertise with stage-appropriate, agile, operational infrastructure that results in companies that are efficient, cost effective, focused and great places to work.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

C-Suite

Entry

Manager

Employees by Department

Pathios Therapeutics has 8 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Pathios Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-10-27	9	$688,100
2024-05-18	5	$25,000,000

Funding Insights

$25,688,100

Total funding amount

$25,000,000

Most recent funding amount

Number of funding rounds

Pathios Therapeutics Tech Stack

Discover the technologies and tools that power Pathios Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

reCAPTCHA

Security

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

YouTube

Video players

Yoast SEO

SEO

Google Workspace

Frequently asked questions

Pathios Therapeutics is located in 99 Park Drive, Milton, GB.

You can reach Pathios Therapeutics at +4410641754.

Pathios Therapeutics generates an estimated annual revenue of $760,000. This revenue figure reflects the company's market position and business performance in its industry.

Pathios Therapeutics has an estimated valuation of $2,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Pathios Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Pathios Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Pathios Therapeutics has raised a total of $25,688,100 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Pathios Therapeutics

Paul G Higham

Chief Executive Officer

4.8

40,000 users